Article

April 24, 2012

If Supreme Court Rejects Obama's Health Law, Employers, Insurers will Drive Their Own Overhaul

If the Supreme Court strikes down President Barack Obama's health care law, employers and insurance companies — not the government — will be the main drivers of change over the next decade and maybe even longer.

They'll borrow some ideas from Obamacare, and push harder to cut costs.

Read the full story: http://hcp.lv/IeOdTw

Source: Chicago Tribune

Related Content

Milton Packer, MD | Image credit: Baylor, Scott, and White

November 16th 2024

For Obesity and HFpEF, Tirzepatide Cuts Risk of CV Death or Worsening HF by 38%

Mary Caffrey

Payers and employers have tightened access to the glucagon-like peptide 1 receptor agonist class once these therapies became more commonly prescribed for obesity.

February 15th 2022

How Can Employers Leverage the DPP to Improve Diabetes Rates?

On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).

Healthcare costs and fees concept.Hand of smart doctor used a calculator for medical costs in modern hospital - everythingpossible - stock.adobe.com

October 31st 2024

Employers Shift to Equity-Focused Strategies as Health Costs Outpace Wages

Giuliana Grossi

As health care costs escalate, a new survey reveals that 74% of employers are grappling with the impact on employee wages and benefits, with many anticipating further cost-shifting to their workforce.

August 31st 2021

Key Issues Influencing 2022 Employer Health Care Strategy and Plan Design

On this episode of Managed Care Cast, we speak with Ellen Kelsay, president and CEO of the Business Group on Health, on the findings from her organization's 2022 Large Employers’ Health Care Strategy and Plan Design Survey.

While shares varied by payer market, 73.6% of retail prescriptions overall were attributed to CVS Caremark, Optum Rx, and Express Scripts in the study. | Image credit: DedMityay - stock.adobe.c

September 10th 2024

A Highly Concentrated PBM Market Highlights Need for Policy Changes

Rose McNulty

The findings may help inform policy changes at the federal level aiming to address unfair and deceptive pharmacy benefit manager (PBM) practices.

August 16th 2024

Kathy Oubre, MS

This article first appeared on The Center for Biosimilars®.